Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer.

GALAXY, an observational arm of CIRCULATE-Japan, measured ctDNA before and after surgery in 1,039 people with stage II-IV resectable colorectal cancer and related it to adjuvant chemotherapy. The abstract excerpt does not name the assay.

Nature MedicinePubMed 36646802DOI 10.1038/s41591-022-02115-4